Identified as
  • v4.0.2
  • FAQ
  • SIGN UP / LOGIN
  • LOGIN

Hatteras Venture Partners

Washington, District of Columbia
cb
Founded:2000
Firm Location:Washington, District of Columbia • Durham, North Carolina • Asheville, North Carolina • Chapel Hill, North Carolina • Burlington, Vermont • Raleigh-Durham / Southeast US
Investor Firms That Co-Invest with Hatteras Venture Partners
RA CapitalJohnson & Johnson InnovationRoche Venture FundAbbVie VenturesPoint Judith CapitalMorpheus VenturesToba CapitalAtlas VentureArboretum VenturesVensana CapitalMayfieldT1D FundCatalio CapitalBroadview VenturesOmega FundsRebel FundOsage University PartnersM Ventures (Merck)Fusion FundDigitalis VenturesCanaan PartnersSOSV5am VenturesOrbiMedGV (Google Ventures)
Hatteras Venture Partners Team
INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
Photo of John Crumpler, General Partner at Hatteras Venture Partners
John Crumpler
Hatteras Venture PartnersGeneral Partner
n/a
$1.5M
($100K - $5.0M)
Investors in Durham (NC)
Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+12
Photo of Mike Dial, Partner at Hatteras Venture Partners
Mike Dial
Hatteras Venture PartnersPartner
n/a
$2.0M
($400K - $4.0M)
Investors in Durham (NC), Investors in Raleigh-Durham / Southeast US
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed)
+22
Photo of Fred Goldwater, Venture Partner at Hatteras Venture Partners
Fred Goldwater
Hatteras Venture PartnersVenture Partner
n/a
$1.5M
($100K - $5.0M)
Investors in Durham (NC)
Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+10
Photo of Robert Ingram, General Partner at Hatteras Venture Partners
Robert Ingram
Hatteras Venture PartnersGeneral Partner
n/a
$1.5M
($100K - $5.0M)
Investors in Durham (NC)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists)
+1
Photo of Myla Lai-Goldman, Venture Partner at Hatteras Venture Partners
Myla Lai-Goldman
Hatteras Venture PartnersVenture Partner
n/a
$1.5M
($100K - $5.0M)
Investors in Burlington (VT)
Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+14
Photo of Kenneth Lee, General Partner at Hatteras Venture Partners
Kenneth Lee
Hatteras Venture PartnersGeneral Partner
n/a
$1.5M
($100K - $5.0M)
Investors in Durham (NC)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists)
+5
Photo of Lauren Pierce Flickinger, Principal at Hatteras Venture Partners
Lauren Pierce Flickinger
Hatteras Venture PartnersPrincipal
n/a
$1.5M
($100K - $5.0M)
Investors in Asheville (NC)
Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+10
Photo of Douglas Reed, General Partner at Hatteras Venture Partners
Douglas Reed
Hatteras Venture PartnersGeneral Partner
n/a
$1.5M
($100K - $5.0M)
Investors in Durham (NC)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+17
Photo of Don Rose, Venture Partner at Hatteras Venture Partners
Don Rose
Hatteras Venture PartnersVenture Partner
n/a
$1.5M
($100K - $5.0M)
Investors in Chapel Hill (NC)
Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+10
Photo of Ben Scruggs, Principal at Hatteras Venture Partners
Ben Scruggs
Hatteras Venture PartnersPrincipal
n/a
$1.5M
($100K - $5.0M)
Investors in Chapel Hill (NC), Investors in Raleigh-Durham / Southeast US
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+13
Photo of Christy Shaffer, General Partner at Hatteras Venture Partners
Christy Shaffer
Hatteras Venture PartnersGeneral Partner
n/a
$1.5M
($100K - $5.0M)
Investors in Chapel Hill (NC)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists)
+1
Photo of Kseniya Simpson, Analyst at Hatteras Venture Partners
Kseniya Simpson
Hatteras Venture PartnersAnalyst
n/a
$1.5M
($100K - $5.0M)
Investors in Chapel Hill (NC), Investors in Raleigh-Durham / Southeast US
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists)
+1
Photo of Jeff Terrell, Partner at Hatteras Venture Partners
Jeff Terrell
Hatteras Venture PartnersPartner
n/a
$1.5M
($100K - $5.0M)
Investors in Raleigh (NC), Investors in Durham (NC)
Investors in Medical Devices (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists)
+4
Photo of Clay Thorp, General Partner at Hatteras Venture Partners
Clay Thorp
Hatteras Venture PartnersGeneral Partner
n/a
$1.5M
($100K - $5.0M)
Investors in Chapel Hill (NC)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A)
+13
Photo of Holden Thorp, Venture Partner at Hatteras Venture Partners
Holden Thorp
Hatteras Venture PartnersVenture Partner
n/a
$1.5M
($100K - $5.0M)
Investors in St. Louis (MO), Investors in Washington (DC)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Midwest (Other Lists)
+10
Photo of Mark Velleca, Venture Partner at Hatteras Venture Partners
Mark Velleca
Hatteras Venture PartnersVenture Partner
n/a
$1.5M
($100K - $5.0M)
Investors in Durham (NC)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists)
+1
Copyright © 2025NFX Capital. We invest.
FAQ Terms Privacy Disclosure
Log in for full access to the Signal investing network

Unlock your intro paths to 30,000+ Pre-Seed, Seed, and Serias A investors. It's free.

Or sign up or log in with email